Evidence map›Paper›PMID 40598491›Full record

ArticleJournal of nanobiotechnology2025

Natural small molecule smart hydrogels inhibited the Hsp90/NF-κB signaling axis in inflammation to achieve sustained antipyretic effect.

Yuqin Yang, Jingyi Jiao, Xiaohui Jia, Lei Li, Meiling Wu, Xinyue Lu, Yangyang Sun, Yingqi Lang, Fuhao Chu, Dong Bai and 2 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuqin Yang *Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Jingyi Jiao *Beijing University of Chinese Medicine, Beijing, 102488, China.
Xiaohui Jia *Beijing University of Chinese Medicine, Beijing, 102488, China.
Lei LiBeijing University of Chinese Medicine, Beijing, 102488, China.
Meiling WuInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Xinyue LuInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yangyang SunInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yingqi LangBeijing University of Chinese Medicine, Beijing, 102488, China.
Fuhao ChuBeijing University of Chinese Medicine, Beijing, 102488, China. 202002019@bucm.edu.cn.
Dong BaiInstitute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China. baidong2000@126.com.
Penglong WangBeijing University of Chinese Medicine, Beijing, 102488, China. wpl581@126.com.
Haimin LeiBeijing University of Chinese Medicine, Beijing, 102488, China. hm_lei@126.com.

Funding

Fundamental Research Funds for the Central Public Welfare Research Institutes YZX-202401Fundamental Research Funds for the Central Universities 2022-JYB-JBZR-016National Natural Science Foundation of China 82204600National Natural Science Foundation of China 82274082
6 · The paper itself

Abstract

In general, pseudoephedrine (PE) is a safe and universally employed in cold medicine, which displays powerful effect on antipyretic. Nonetheless, the sustained drug delivery system can effectively put an end to the above problems attributable to the drawbacks of low bioavailability and short intervals of administration. "Complexation" hydrogels are capturing enormous attention in a diverse array of fields in that there is no necessity to carry out external intervention for drug delivery. Nevertheless, it is prevalently acknowledged that macromolecular "complexation" hydrogels, biotin/avidin, antibodies/antigens, heterodimers, conA/glucose and cyclodextrin (CD) inclusion complexes, have several limitations of conventional drug delivery systems, such as unfavorable biological safety, undesirable intestinal wall penetrating, and extremely limited biodegradability, etc. For this reason, it is tremendously imperative to develop a natural small "complexation" hydrogel. In this context, we innovated a direct self-assembly "complexation" hydrogel (PE-GA). The PE-GA hydrogel was prepared by the incorporation of PE and glycyrrhizic acid (GA) into an aqueous dispersion without the aid of other carriers, which demonstrated dual-responsiveness including heating-cooling as well as pH. It is mainly governed by hydrogen bonds and electrostatic interactions. For cell bioavailability, there were substantial discrepancies between the PE-GA hydrogel and free PE at 72 and 84 h. For pharmacokinetic properties, there was also conspicuous discrepancy in Area Under the Curve (AUC) values between them. In subsequent antipyretic assay, PE-GA hydrogel displayed a conspicuous antipyretic effect in fever rats induced by LPS. The non-invasive fluorescence imaging was utilized to monitor the intestinal retention of the PE-GA hydrogel in mice, its unique aggregation/assembly induced retention (AIR) effect reinforced bioactive molecule retention, which may be another manifestation of enhancing antipyretic effect. Aside from that, PE-GA hydrogel played an antipyretic role by Hsp90/NF-κB pathway. The current research revealed potential antipyretic effect of PE-GA hydrogel which could be the therapeutic option against fever.

Indexed as

AntipyreticsHSP90 Heat-Shock ProteinsHydrogelsInflammationNF-kappa BAnimalsFeverGlycyrrhizic AcidHumansMaleMiceRatsRAW 264.7 CellsSignal TransductionAntipyreticsGlycyrrhizic AcidHSP90 Heat-Shock ProteinsHydrogelsNF-kappa B

Identifiers

PMID40598491
PMCPMC12210914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.